TREATMENT FOR LOCAL FORMS OF ALOPECIA AREATA, BY TAKING INTO ACCOUNT THE PATHOGENETIC FEATURES OF DISEASE DEVELOPMENT

Download full text PDF
Issue: 
2
Year: 
2017

A. Gadzhigoroeva, MD Moscow Research and Practical Center for Dermatovenereology and Cosmetology, Department of Healthcare, Moscow

Intradermal injections of long-acting corticosteroids, the dose of which is limited by possible side effects, are used to treat local forms of alopecia areata (AA), which makes them unacceptable for extensive balding areas. In this connection, it is relevant to study the efficiency of treatment for local forms of AA by alternative topical immunosuppressive therapies.
Keywords: 
alopecia areata
activity
angiogenesis
treatment
minoxidil
hormones

It appears your Web browser is not configured to display PDF files. Download adobe Acrobat или click here to download the PDF file.

References: 
  1. Fomkina I.G. Kompleksnaja patogeneticheskaja terapija bol'nyh ochagovoj alopetsiej s uchetom pokazatelej gemostaza i reologii krovi. Dis. … kand. med. nauk. M., 1997.
  2. Chase N. Cycles and waves of hair growth. In: Biology of the Skin and Hair Growth. Edited by A. Lyne, B. Short / Sydney, Australia: Angus & Robertson, 1965; p. 461–5.
  3. Sagindikova G.E., Kogan E.A., Satbaeva E.B. i dr. Matriksnye metalloproteinazy i ih ingibitory v protsessah angiogeneza, fibroza i disregeneratsii epitelija pri hronicheskih zabolevanijah legkih u lits, dlitel'noe vremja prozhivavshih na radioaktivno-zagrjaznennyh territorijah Semipalatinskoj oblasti Kazahstana // Ros. biomed. zhurn. Medline.ru. – 2007; 8: 476–89.
  4. Sarkisov D.S. Strukturnye osnovy adaptatsii i kompensatsii narushennyh funktsij / M.: Meditsina, 1987.
  5. Gadzhigoroeva A.G. Minoksidil v lechenii alopetsii // Vestn. dermatol. i venerol. – 2006; 5: 87–93.
  6. Fiedler-Weiss V. Topical minoxidil solution (1% and 5%) in the treatment of alopecia areata // J. Am. Acad. Dermatol. – 1987; 16: 745–8.
  7. Ferry J., Fiedler V. Pilot study to evaluate the effect of topical betamethasone dipropionate on the percutaneous absorption of minoxidil from 5% topical solution // J. Invest. Dermatol. – 1990; 94: 524.
  8. Fiedler V., Wendrow A., Szpunar G. et al. Treatment-resistant alopecia areata. Response to combination therapy with minoxidil plus anthralin // Arch. Dermatol. – 1990; 126 (6): 756–9.
  9. Olsen E., Carson S., Turney E. Systemic steroids with or without 2% topical minoxidil in the treatment of alopecia areata // Arch. Dermatol. – 1992; 128 (11): 1467–73.
  10. Price V. Topical minoxidil in extensive alopecia areata, including 3-year follow-up // Dermatologica. – 1987; 175 (2): 36–41.
  11. Warshaw E., Botto N., Maibach H. et al. Positive patch-test reactions to propylene glycol: a retrospective cross-sectional analysis from the North American Contact Dermatitis Group, 1996 to 2006 // Dermatitis. – 2009; 20: 14–20.
  12. Lessmann H., Schnuch A., Geier J. et al. Skin-sensitizing and irritant properties of propylene glycol // Contact Dermatitis. – 2005; 53: 247–59.
  13. Olsen E., Whiting D., Bergfeld W. et al. A multicenter, randomized, placebo-controlled, doubleblind clinical trial of a novel formulation of 5% minoxidil topical foam versus placebo in the treatment of androgenetic alopecia in men // J. Am. Acad. Dermatol. – 2007; 57 (5): 767–74.
  14. Olsen E., Dunlap F., Funicella T. et al. A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men // J. Am. Acad. Dermatol. – 2002; 47: 377–85.